© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Levofloxacin Hydrochloride stands among the most relied-on antibacterial raw materials in hospitals and pharmaceutical manufacturing. The compound, recognized for its strong efficacy against a massive range of bacteria, provides the active center of various antibiotic products. Chemically, Levofloxacin Hydrochloride emerges from quinolone carboxylic acid derivatives. Its IUPAC name, (S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hydrochloride, hints at its complex structure and potent mechanism of action. Most bulk shipments carry the HS Code 29419090, which puts it within pharmaceutical active ingredients with chemical complexity and biological potency.
In molecular terms, Levofloxacin Hydrochloride bears the formula C18H21FN3O4•HCl. Each molecule features a fluorine atom attached to a polycyclic quinolone backbone, and the hydrochloride part increases solubility in aqueous solutions. The molecular weight clocks in at approximately 397.85 g/mol. Its geometry brings together aromatic rings, a carboxylic acid group, and a piperazinyl substituent. These features combine to give the compound both chemical resilience and specific activity against DNA gyrase and topoisomerase IV, targets inside bacterial cells.
Levofloxacin Hydrochloride usually appears as a white or pale yellow powder, though some preparation steps at manufacturing scale result in crystalline or flaked forms. Tactile handling always reveals a fine and loose consistency, typical for raw pharmaceutical powders. The powder’s density measures around 1.5 g/cm³. Solid at room temperature, the material does not form pearls or flakes unless specifically processed, though some crystallization can happen during certain storage conditions or after lyophilization. Under direct illumination, the crystalline form displays a slight sheen, a small clue to its purity and well-defined molecular organization.
As a hydrochloride salt, the compound dissolves easily in water, forming a clear, pale-yellow solution. Solubility in ethanol, methanol, and similar solvents is lower but still appreciable, which opens up process options in both research labs and industrial reactors. The solution pH typically ranges from 3.5 to 5.5 at standard concentration, reflecting the presence of the hydrochloride ion and acidic carboxyl group. The material’s stability under normal atmospheric conditions means that storage does not demand exotic protections, but humidity-free, temperature-controlled rooms extend shelf life, which sits right with best manufacturing practices. Those working in pharmaceutical QA labs see these factors daily—the clarity of a solution or the ease of dissolving a raw batch can hint at process quality and downstream product safety.
In occupational settings, Levofloxacin Hydrochloride carries certain health risks that require careful mitigation. The dust can trigger mild irritation in respiratory tracts or on contact with skin and eyes—tasks involving bulk material always call for masks, gloves, and safety glasses. Larger accidental spills need prompt cleanup under ventilated hoods to avoid aerosolization. Toxicology data flags harmful effects on aquatic organisms, so industrial waste requires proper treatment before disposal. Chronic exposure to antibiotic powders can trigger sensitization for some workers and, in poorly managed facilities, contribute to the development of antibiotic-resistant bacterial strains in the environment. Manufacturing practice and worker training become as crucial as the chemical’s purity specifications—there is simply no shortcut around rigorous safety culture.
Good manufacturing practice and regulatory standards both set tough rules for batch purity. Pharmaceutical grade Levofloxacin Hydrochloride must exceed 98.5% assay, with impurity profiles tightly controlled by HPLC or similar chromatographic methods. Moisture content stays below 0.5% in order to maintain stability through long storage periods. Solutions for clinical or research use must show complete clarity, no insoluble particles, and accurate pH range. Incoming shipments demand COAs (certificates of analysis) and traceability back to original batch records—a process familiar to anyone handling regulated APIs day in, day out. Storage involves sealed, light-proof containers in cool, dry rooms, ensuring the material resists both chemical breakdown and unwanted absoprtion of atmospheric moisture. Raw material quality links directly to patient safety, placing responsibility in every chemist’s hands during verification and handling.
Pharmaceutical manufacturers use Levofloxacin Hydrochloride primarily as a raw material for tablets, injectables, and ophthalmic solutions. Batch mixing and granulation steps need consistent, flowable powders; here, the specific particle size distribution influences how easily a batch can blend or compress. In solution, the hydrochloride salt grants a stable and bioavailable active ingredient. Techs and operators use high-quality analytical tools—ranging from titration to spectroscopy—to validate each process stage. Robust protocols block cross-contamination with other antibiotic classes, protecting against undesired interactions in downstream products. Experience from industrial-scale operations shows how small variances in raw powder quality echo throughout the final dosage form, reinforcing the role of meticulous materials management.
Production of Levofloxacin Hydrochloride leans on the chemical synthesis of chiral intermediates, fluorinated aromatics, and piperazine reagents. Each step uses solvents, reagents, and catalyst systems that demand responsible waste management. Modern manufacturers look to shift toward greener chemistry, investigating ways to recover solvents and reduce hazardous byproduct volumes. Regulatory agencies scrutinize each stage for trace impurities, especially those with known or suspected environmental toxicity. In daily work, chemists and engineers balance optimization for yield, purity, and waste minimization, aiming for safer and more sustainable outputs. The continuous drive for higher process efficiency and reduced environmental impact rewards teams prepared to adopt new process technologies and rethink raw material sourcing each year.
